Karolinska Development AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KDEV.ST research report →
Companywww.karolinskadevelopment.com
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark.
- CEO
- Viktor Drvota
- IPO
- 2011
- Employees
- 8
- HQ
- Solna, SE
Price Chart
Valuation
- Market Cap
- $80.86M
- P/E
- -0.70
- P/S
- 29.49
- P/B
- 0.14
- EV/EBITDA
- 0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 81.84%
- Op Margin
- -7806.67%
- Net Margin
- -7797.16%
- ROE
- -19.50%
- ROIC
- -19.26%
Growth & Income
- Revenue
- $10.80M · 487.65%
- Net Income
- $-193,855,000 · -2292.98%
- EPS
- $-0.58 · -1833.33%
- Op Income
- $-194,124,000
- FCF YoY
- 6.36%
Performance & Tape
- 52W High
- $1.34
- 52W Low
- $0.22
- 50D MA
- $0.35
- 200D MA
- $0.78
- Beta
- 0.39
- Avg Volume
- 2.64M
Get TickerSpark's AI analysis on KDEV.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KDEV.ST Coverage
We haven't published any research on KDEV.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KDEV.ST Report →